Are We Recognizing Perimenopause Too Late?
For decades, the menopause conversation has followed a familiar timeline.
A woman enters her mid-40s. Her periods become irregular. Sleep changes. Anxiety appears. Hot flashes begin. Brain fog becomes more noticeable. Eventually, her periods stop and menopause arrives.
The assumption has always been that these symptoms mark the beginning of the transition.
What if they don't?
A remarkable study published in 2025 analyzed more than 300 million laboratory tests from over one million women across two healthcare systems. Rather than focusing on symptoms, researchers examined how biological markers changed before, during, and after menopause.
What they found challenges one of the most fundamental assumptions in menopause research.
Evidence of sex hormone dysregulation appeared more than a decade before the final menstrual period.
Not one year.
Not two years.
More than ten.
If these findings hold up, they force us to ask a difficult question.
Are we recognizing perimenopause too late?
Table of Contents
- The Question Researchers May Have Been Asking Backwards
- What Researchers Found in More Than 300 Million Lab Tests
- The 10-Year Question
- The Biological Cliff
- The Deeper Question
- What Does This Mean for Women in Their 30s?
- What Researchers Still Don't Know
- The Detection Problem
- Key Takeaways
- Frequently Asked Questions
- References
The Question Researchers May Have Been Asking Backwards
One of the assumptions underlying modern menopause care is that perimenopause begins when symptoms appear. A woman notices her cycles becoming irregular, sleep becomes less restorative, anxiety appears unexpectedly, brain fog becomes more noticeable, or hot flashes begin, and the transition is considered to have started.
The challenge is that symptoms tell us when a process becomes visible. They do not necessarily tell us when that process began.
This distinction sits at the heart of what makes this study so interesting. By analyzing more than 300 million laboratory tests, the researchers were not measuring symptoms. They were measuring biology. What they found suggests that hormonal dysregulation may be occurring years before the changes most women associate with perimenopause.
If that observation is correct, then it raises an uncomfortable possibility. We may have anchored our definition of perimenopause to the point at which the transition becomes noticeable rather than the point at which it begins.
This would not be unique to menopause. Much of medicine operates this way. A heart attack is not the beginning of cardiovascular disease. A fracture is not the beginning of osteoporosis. The diagnosis often occurs long after the underlying biology has started to change.
The question raised by this study is whether menopause follows a similar pattern. Have we mistaken the moment we recognize the transition for the moment it actually starts?
What Researchers Found in More Than 300 Million Lab Tests
Most headlines focused on the finding that evidence of hormonal dysregulation appeared more than a decade before menopause.
What caught my attention was something else.
The study itself was unusual. Researchers analyzed more than 300 million laboratory tests from over one million women and developed a mathematical framework that allowed them to reconstruct biological changes around the final menstrual period on a scale that has rarely been possible before.
That matters because one of the biggest challenges in menopause research is timing. Researchers often know when a woman enters a study, but they do not always know where she is within the menopause transition itself. This approach allowed the authors to examine physiological changes before, during, and after menopause across an enormous population.
What emerged was not simply a story about hormones.
Researchers identified menopause-associated changes across metabolic, inflammatory, cardiovascular, bone, liver, kidney, lipid, muscular, and hematological markers.
That finding may be one of the most important observations in the entire paper.
For decades, menopause has largely been discussed through a reproductive lens. The conversation typically revolves around estrogen, fertility, menstrual cycles, and symptom management.
The data emerging from this study suggests something much larger may be occurring.
If multiple biological systems are changing alongside ovarian aging, then menopause may be less accurately described as a reproductive transition and more accurately described as a systemic physiological transition. A reproductive event affects fertility. A systemic event affects the entire body. That difference changes the questions researchers ask, the way clinicians think about the transition, and potentially how women's symptoms are interpreted.
This is one reason I believe the most important finding in the paper is not the timeline itself.
It is the pattern.
The researchers found evidence that multiple systems appear to be moving together.
The obvious question is why.
And that question may ultimately prove more important than the ten-year timeline that generated most of the headlines.
The 10-Year Question
The headline finding from the study was that evidence of sex hormone dysregulation appeared more than a decade before the final menstrual period.
It is a striking finding, but it is also one that requires careful interpretation.
The study does not suggest that women are experiencing hot flashes, brain fog, anxiety, sleep disturbances, or other classic symptoms of perimenopause for ten years before menopause. Nor does it suggest that every woman in her late 30s is unknowingly in perimenopause.
What the researchers observed was biological change.
It changes what we are actually looking for.
One of the recurring challenges in medicine is that biological processes and symptoms rarely emerge at the same time. The body often begins adapting long before those changes become noticeable. By the time symptoms appear, the underlying biology may have been shifting for years.
The question raised by this study is whether ovarian aging follows a similar pattern.
If hormonal dysregulation can be detected years before menopause, then the transition may be beginning long before we currently recognize it. The challenge is that researchers still do not know how these early biological changes relate to the symptoms women experience later.
This creates an interesting possibility.
Some women may experience symptoms relatively early in the process. Others may remain largely asymptomatic despite measurable biological change. Still others may move through much of the transition without recognizing what is happening at all.
At present, we simply do not know.
What we do know is that the timeline appears to be longer than previously appreciated.
For me, that may be one of the most important implications of the paper. It encourages us to stop thinking about menopause as a single event and start thinking about it as a process. The final menstrual period may be one milestone within that process, but it may not represent the beginning of the story.
And if that is true, then one of the most important questions in menopause research is no longer when menopause occurs.
It is when ovarian aging actually begins.
The Biological Cliff
One of the most intriguing findings in the paper received far less attention than the ten-year timeline.
Researchers observed that many physiological markers did not change gradually throughout the menopause transition. Instead, a surprising number appeared to undergo relatively abrupt shifts around the final menstrual period.
The authors described these as step-like changes.
At first glance, this may seem like a technical observation.
I don't think it is.
If ovarian aging begins years before menopause, as the study suggests, then why do so many biological markers appear to remain relatively stable before changing more dramatically around the same point in time?
That question is difficult to ignore.
The traditional view of menopause assumes a gradual process. Ovarian function declines, hormone production changes, symptoms emerge, and the transition unfolds over time.
The data suggests something more complex may be happening.
It raises the possibility that the body spends years adapting to declining ovarian function before reaching a threshold where that adaptation becomes more difficult to maintain.
If that interpretation is correct, then menopause may not be best understood as a slow decline. It may be more accurately understood as a long period of compensation followed by a series of biological tipping points.
That possibility helps explain something many women have described for years.
The transition itself often does not feel gradual.
Women frequently report reaching a period where multiple aspects of their health seem to change within a relatively short timeframe. Sleep changes. Recovery changes. Metabolic health changes. Cognitive changes become more noticeable. Symptoms that were once occasional become more persistent.
The conventional explanation has been that these changes are simply part of aging.
This study raises another possibility.
Some of these shifts may reflect the point at which the body's ability to compensate for ovarian aging begins to change.
The paper cannot tell us whether that interpretation is correct.
What it does tell us is that multiple physiological systems appear to be responding around the same stage of the transition.
For me, that raises a much more interesting question than whether menopause begins ten years earlier.
What exactly has the body been compensating for during those ten years?
And what role has the ovary been playing in maintaining that stability?
The Deeper Question
The finding that hormonal dysregulation may begin more than a decade before menopause is fascinating.
The finding that multiple physiological systems appear to move together is even more interesting.
But neither is the question that stayed with me after reading the paper.
The question that stayed with me was this: what exactly is the ovary doing during those years?
If ovarian aging is already underway, yet many physiological systems remain relatively stable, then something important is happening beneath the surface.
The paper suggests that biological changes begin years before menopause. It also suggests that multiple systems respond as the transition progresses. What it does not explain is how stability is maintained for so long before those larger shifts occur.
That is where I think the most interesting questions begin.
For decades, the ovary has largely been viewed through the lens of reproduction. We tend to think about fertility, menstrual cycles, ovulation, estrogen production, and eventually menopause.
Yet the systems highlighted in this study extend far beyond reproduction.
Researchers observed changes in markers related to metabolism, inflammation, cardiovascular health, bone health, liver function, kidney function, and blood physiology.
Those systems are not random. Nor are they confined to fertility.
This is why I find it difficult to view the paper as simply a menopause study.
What if it is also a study about the role of the ovary itself?
If ovarian aging can be detected years before menopause, and if multiple physiological systems appear to respond alongside it, then perhaps we have underestimated the influence of the ovary on overall health.
Perhaps the ovary is not merely participating in these processes.
Perhaps it has been helping coordinate them all along.
The paper does not prove that. But it certainly raises the possibility.
And if future research supports that idea, the implications are profound.
The conversation shifts from how we manage menopause to understanding what is lost as ovarian function declines. It shifts from fertility to physiology. From reproductive aging to systemic aging.
This may be the question hiding beneath the entire study.
Not when menopause begins.
Not when symptoms begin.
But what role the ovary has been playing throughout the decades that came before.
What Does This Mean for Women in Their 30s?
This is where the findings become particularly difficult to ignore.
If evidence of hormonal dysregulation can be detected more than a decade before menopause, then what does that mean for women who have not yet reached their mid-40s?
The study does not suggest that every woman in her 30s is in perimenopause. Nor does it suggest that every unexplained symptom should be attributed to ovarian aging.
What it does suggest is that the timeline may be more complicated than we once believed.
A woman who reaches menopause at 50 may have been experiencing biological changes in her late 30s. A woman who reaches menopause at 45 may have entered that process even earlier. Women with Primary Ovarian Insufficiency, accelerated ovarian aging, endometriosis, certain autoimmune conditions, or a strong family history of early menopause may follow a different timeline altogether.
This is where I think the paper raises an important clinical question.
If we define perimenopause primarily through symptoms, what happens to women whose biology is changing before those symptoms become obvious? Or perhaps more importantly, what happens to women whose symptoms do not fit the picture we expect?
Many women in their late 30s describe subtle changes long before they experience hot flashes or irregular cycles. Sleep becomes less restorative. Recovery from stress changes. Energy shifts. Mood becomes less predictable. Cognitive stamina feels different. Something feels off, yet standard explanations often fail to fully account for what they are experiencing.
That does not mean every one of these women is in perimenopause.
It does mean we should be cautious about assuming they are too young to be part of the conversation.
One of the limitations of a symptom-based model is that it encourages us to look for changes only after they become obvious. The possibility raised by this study is that the underlying biology may already be evolving long before the transition becomes visible.
If that proves to be true, then younger women may expose one of the biggest weaknesses in our current understanding of perimenopause.
We may be looking for the transition too late.
And if we are looking too late, then we may also be asking the wrong questions.
What Researchers Still Don't Know
As remarkable as this study is, it leaves some of the most important questions unanswered.
The researchers identified evidence of biological change years before menopause. What they did not establish is how those changes relate to the experiences women report throughout the transition.
This may sound surprising, but it highlights one of the biggest gaps in menopause research.
Women have long described changes that seem to precede the traditional markers of menopause. Changes in sleep, cognition, mood, stress tolerance, energy, recovery, and overall resilience are frequently reported years before the final menstrual period. Yet researchers still do not fully understand how these experiences connect to the underlying biology.
The challenge is not that women have failed to describe what they are experiencing.
The challenge is that we still lack the tools to accurately map those experiences to the biological changes occurring beneath the surface.
This study suggests that hormonal dysregulation may begin years before menopause. What it cannot tell us is why some women experience profound symptoms while others experience very few. It cannot tell us which biological changes matter most, which systems are driving symptoms, or when those changes become clinically significant.
Nor can it answer the question that emerged repeatedly as I read the paper.
If biological changes can be detected more than a decade before menopause, what is happening during those years? What systems are adapting? What systems are compensating? And at what point does compensation begin to fail?
These are not small questions. They sit at the center of how we understand ovarian aging, menopause, and women's health more broadly.
For decades, menopause research has focused on the final menstrual period because it is relatively easy to identify. This study suggests that the years preceding it may be equally important.
The most significant contribution of this paper may not be the answers it provides.
It may be the questions it forces us to ask.
The Detection Problem
If biological changes associated with ovarian aging can begin more than a decade before the final menstrual period, a difficult question follows: how many women are moving through the earliest stages of that process without any reliable way to identify it?
This question sits at the center of a much larger conversation about how perimenopause is currently tested and diagnosed. For a detailed look at the limitations of FSH, estradiol, and AMH testing — and what a normal result can and cannot tell you — see Why Is Perimenopause So Difficult to Test?
Key Takeaways
- A 2025 study analyzing more than 300 million laboratory tests found evidence of sex hormone dysregulation more than a decade before the final menstrual period.
- The study suggests that biological changes associated with menopause may begin years before the symptoms most women associate with perimenopause.
- Researchers observed changes across multiple physiological systems, including metabolic, inflammatory, cardiovascular, bone, liver, kidney, and blood-related markers, suggesting menopause may be a systemic biological transition rather than a purely reproductive one.
- Many laboratory markers appeared to change in a step-like fashion around the final menstrual period, raising the possibility that some aspects of menopause may function more like biological thresholds than gradual declines.
- The most important implication of this research may not be that menopause begins earlier than we thought, but that we still do not know exactly when the transition begins.
Frequently Asked Questions
Does this study prove that perimenopause starts 10 years before menopause?
No. The study found evidence of hormonal dysregulation more than a decade before the final menstrual period. What it does not establish is when perimenopause begins or when symptoms first appear. Biological changes and symptoms are not necessarily the same thing.
Does hormonal dysregulation mean I will experience symptoms?
Not necessarily. One of the major unanswered questions raised by this research is how biological changes relate to lived experience. Some women experience significant symptoms during the menopause transition, while others experience relatively few. Researchers still do not fully understand why.
If biological changes begin earlier, why don't current tests detect them?
This is one of the most important implications of the paper. Many of the tools currently used to identify perimenopause rely on symptoms, menstrual changes, or hormone measurements that fluctuate significantly throughout the transition. The study raises the possibility that some biological changes may occur before these traditional markers become obvious.
What is the difference between ovarian aging and menopause?
Menopause is a milestone defined retrospectively after twelve consecutive months without a menstrual period. Ovarian aging refers to the gradual biological changes occurring within the ovaries over time. This study suggests those changes may begin years before menopause itself.
Why is the final menstrual period still important?
The final menstrual period remains one of the most important markers in menopause research because it provides a clearly identifiable point within the transition. What this study questions is whether it should also be considered the beginning of the story.
Why does this study matter?
For decades, menopause research has focused primarily on the years immediately surrounding the final menstrual period. This study suggests the biological timeline may be much longer than previously appreciated. If confirmed, it could change how researchers study menopause, how clinicians think about the transition, and how women understand the changes occurring within their own bodies.
References
- Alon U, et al. (2025). Dynamics of Menopause from Deconvolution of Millions of Lab Tests. arXiv.
https://arxiv.org/abs/2511.05906 - Brinton RD, Mosconi L, Rahman A, et al. (2026). Menopause-Related Brain Fog as a Midlife Window in Women's Brain Health. Frontiers in Human Neuroscience, 20, 1814092.
https://www.frontiersin.org/journals/human-neuroscience/articles/10.3389/fnhum.2026.1814092/full - Mishra GD, et al. (2026). Advances in Understanding of Cognitive Symptoms During Menopause. The Lancet Regional Health Europe.
https://doi.org/10.1016/S3050-5038(26)00043-9 - International Federation of Gynecology and Obstetrics (FIGO). (2026). Best Practice Recommendations for the Mental Health of Women at Menopausal Age.
https://obgyn.onlinelibrary.wiley.com/doi/full/10.1002/ijgo.70943 - University of Melbourne. (2026). Understanding Brain Fog in Menopause Needs More Data, Experts Say.
https://mdhs.unimelb.edu.au/news-and-events/understanding-brain-fog-in-menopause-needs-more-data%2C-experts-say - UCL News. (2026). Brain Fog Affects Two Thirds Going Through Menopause Yet Remains Poorly Understood.
https://www.ucl.ac.uk/news/2026/apr/brain-fog-affects-two-thirds-going-through-menopause-yet-poorly-understood - Human Reproduction. (2025). Endometriosis and Risk of Early or Surgical Menopause.
https://academic.oup.com/humrep - JAMA Cardiology. (2025). Natural Premature Menopause and Lifetime Risk of Coronary Heart Disease.
https://jamanetwork.com/journals/jamacardiology